ARS Investment Partners’s Corteva CTVA Stock Holding History

ARS Investment Partners’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-666	Closed	-$38K	–	155
2022 Q3	$38K	Buy	+666	New	+$38.8K	0.01%	170

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ARS Investment Partners's CTVA Position: Q4 2022 in Review

ARS Investment Partners sold out of Corteva (CTVA) in Q4 2022, closing a stake of 666 shares — an estimated $38K sold.

ARS Investment Partners first reported a position in CTVA in Q3 2022 and held it in 1 quarter. The position peaked at $38K in Q3 2022. 1,301 funds tracked by Wall St. Rank hold CTVA as of Q4 2022.

ARS Investment Partners reported no remaining Corteva position as of Q4 2022 after selling out during the quarter.
ARS Investment Partners sold 666 Corteva shares in Q4 2022, an estimated $38K.
ARS Investment Partners first reported a position in Corteva in Q3 2022 and held it in 1 quarter.
ARS Investment Partners's Corteva position peaked at $38K in Q3 2022.
1,301 funds tracked by Wall St. Rank held Corteva as of Q4 2022.

Based on ARS Investment Partners's 13F filing for Q4 2022, filed 25 Jan 2023.